World Of Taxonomy
WoT
Galaxy
Crosswalks
Explore
Codes
Guide
Blog
Builders
About
Pricing
Classify My Business
Classify
Sign in
Home
NCI Thesaurus
C20189
C25337
C25337
Level 2
Number
GET
/api/v1/systems/nci_thesaurus/nodes/C25337
Official Download
CC BY 4.0
Source
Hierarchy Explorer
Hierarchy Explorer
Click to expand - equivalences appear inline
C101677
FDA Device Listing Number
C102443
Number of Hospitalization Days
C106550
Number of Abortions
C106551
Number of Pregnancies
C111314
Slice Number
C112364
Number of Coil Channels
C116125
Number of Slices
C117303
Maximum Number of Actual Assessments
C117891
Number of Correct Eye Chart Letters
C120834
Number of Late Fetal Deaths
C122189
Number of Early Term Births
C124281
Number of Episodes
C124443
Number of Hospitalizations
C124446
Number of Lymph Nodes Examined
C124447
Number of Lymph Nodes Positive
C124482
Number of Ossified Skeletal Elements
C124619
Corpora Lutea Number
C124620
Number of Dead Fetuses
C124622
Number of Live Female Fetuses
C124623
Number of Live Male Fetuses
C124624
Number of Live Fetuses
C124626
Number of Fetuses
C124631
Number of Implantations
C124632
Number of Intrauterine Deaths
C124635
Number of Early Resorptions
C124636
Number of Late Resorptions
C124637
Number of Resorptions
C126059
EMA Decision Number for Pediatric Investigation Plan
C126063
Number of Groups or Cohorts
C127111
Drug Refills
C127787
Total Number
C127795
Number of Trial Sites within European Union State
C130057
Number of Events
C130195
Number of Renal Arteries
C130196
Number of Renal Veins
C135500
Number of Biological Brothers
C135501
Number of Biological Sisters
C138077
Number of Pulmonary Nodules
C139054
Number of Cardiac Valve Cusps
C139092
Number of Malignant Biopsy Cores
C139242
Number of Eye Chart Lines Read
C139267
Number of Stillbirths
C139283
Number of Nucleotide Markers Exhibiting Instability
C142987
Number of Metastases
C147480
Number of Points for Lambda z TAU
C148278
Number of Prostate Tissue Cores Positive for Carcinoma
C150827
Number of Occurrences
C153145
Enrolled Study Subject Number
C154713
Number of Electroencephalogram Electrodes
C154906
Number of Electrocardiogram Electrodes
C154907
Number of Electrooculogram Electrodes
C154908
Number of Electromyogram Electrodes
C156495
Number of Unsuppressed Water Averages
C157389
Number Used Since Last Visit
C157390
Number Used at Visit
C158275
Number of Births
C158640
Number of Known Primaries at the Time of Initial Melanoma Diagnosis
C158696
Number of Primary Tumors in this Location
C158697
Number of Units
C158861
Days to Absolute Neutrophil Count Greater than 1000 per Microliter
C158862
Days to Platelet Count Greater than 100,000 per Microliter
C161821
Negative Exponent
C164492
DICOM Series Count
C164563
Number of Supply Days
C164569
Ordered Number of Repeats
C164572
Passage Number
C164667
Sequence Read Count
C164984
Performed Progress Count With Attribute Count
C166208
Chemotherapeutic Cycle Number
C166221
Treatment Cycle Day Number
C166235
Medication Course Number
C166241
Number of Prior Regimens
C168918
Number of Cells in Metaphase during Karyotyping
C171196
Pill count
C172300
Read Pair Number
C172478
Number of Laps Completed
C172479
Number of Steps Taken
C172481
Number of Bulbs
C173293
Number of Doses
C173301
Number of Evaluated HLAs
C173302
Number of Matched HLAs
C173777
Basic Reproduction Number
C173778
Effective Reproduction Number
C174228
Number of Procedures Performed
C174274
Number of Strictures
C174275
Number of Objects
C174277
Number of Lesions
C174283
Number of Servings
C175885
Number of Cases
C176276
Number of Tissue Samples in Specimen
C176277
Number of Devices Present
C177370
Number of Chromosomes on Karyotype
C178041
Number of Biopsy Specimens Affected
C178956
Number of False Negatives
C178957
Number of False Positives
C178958
Number of True Negatives
C178959
Number of True Positives
C181312
Number of Fistulas
C181313
Number of Abscesses
C181317
Number of Biopsy Specimens Taken
C181340
Fragment Count
C181348
Number of Altered Exons
C181350
Number of Sequence Variants
C181528
Number of Continuous Days of Menstrual Bleeding and/or Spotting
C182044
Number of Prostatic Chips Positive
C182045
Number of Recovered Cells Expected
C182046
Number of Years in Occupation
C182047
Number of RECIST Baseline Target Lesion
C182264
Number of Rebiopsy Samples Collected
C182265
Number of Biopsies
C184464
Number of Alcoholic Drinks Measurement
C185198
Trial 1 Correct
C185199
Trial 5 Correct
C185200
Trial B Correct
C185201
Trials 1-5 Correct
C185202
Short Delay Free Recall Correct
C185203
Long Delay Free Recall Correct
C185210
Intrusion Errors Trials 1-5
C185211
Intrusion Errors Free Recall
C185212
Intrusion Errors Cued Recall
C185656
Number of Units of Product Transfused
C189358
Number of Cesarean Sections
C189359
Number of Vaginal Deliveries
C192242
Number of Sessions in Therapy Course
C192526
Fraction Number of Treated Plan
C192527
Number of Clinical Trials Participated
C192528
Number of CT Images Used in Session
C192529
Number of Fractions Intended
C192530
Number of Fractions Treated
C192531
Number of kV Images Used in Session
C192532
Number of MV Images Used in Session
C192533
Number of Prescribed Radiation Therapy Sessions
C192534
Number of Treatment Course Sessions
C192535
Number of Treatment Sessions per Day
C192536
Number of Treatment Sessions per Week
C192537
Number of Years from Prior Treatment
C192538
Treated Plan Fraction Number
C192539
Treatment Course Session Number
C198197
Number of Disease-Involved Anatomic Sites
C198204
Tumor Grade Evaluation Tier Number
C198360
Number of First Degree Biological Relatives
C198363
Number of People in Household
C201469
Threshold Number
C202160
Number of Values in Staining Intensity Scale
C202259
Number of Cells
C204040
Country Dial-in Code
C204093
Reagent Cycle Number
C204094
Reagent Sub-Cycle Number
C204717
FDA CTP Submission Tracking Number
C205025
Number of Dose Orifices Drilled Count
C207509
Narrative Content Section Number
C207537
Study Amendment Number
C209474
Number of Derived Specimens
C209561
Number of Centromere Signals
C209563
Number of Genome-Specific Target Signals
C210199
Number of Heating Elements
C215609
Document Content Reference Section Number
C225450
Number of Maze Errors
C226162
Number of Returns to Maze Start Point
C226182
Number of Stools
C226192
Number of Trial Attempts
C226194
Number of Urine Pools
C40978
Telephone Number
C47864
Mitotic Count
C48923
Exponent
C49142
Copy Number
C53619
Corrective Action Number
C62138
Area Code
C62139
Telephone Extension Number
C62438
Number Type
C64200
log2
C69267
Number of Frames
C69283
Beat Number
C70710
Sequence Number
C70763
Priority Number
C75752
Areic Number
C75941
log10
C78175
Bitmask
C79966
LogE
C80426
Coronary Artery Number of Diseased Vessels (Excludes Left Main Disease)
C80489
Denominator
C82543
Adverse Event Line Number
C82544
Medical History Line Number
C82545
Planned Time Point Number
C83097
Concomitant Medication Adverse Event Number
C83098
Concomitant Medication Medical History Number
C83100
Study Site Number
C83101
Visit Number
C88075
Number of Animals Affected
C88076
Number of Defective Units
C88077
Number of Units Returned
C88211
Base Number
C89579
Fixed-Point Number
C93574
Group Number
C93587
Lesion Number
C93621
Periodic Target Accrual Number
C93628
Position Number
C93651
Repetition Number
C93662
Review Board Approval Number Text
C99996
Number of Diseased Coronary Artery Vessels
Cross-system equivalences
0
No cross-system equivalences mapped for this node.
Report a data issue